SYSTEMATIC REVIEW article
Front. Oncol.
Sec. Cancer Metabolism
This article is part of the Research TopicObesity, inflammation and immunity: new insights into cancer development and progressionView all articles
Body Mass Index and Prostate Cancer Incidence: A Comprehensive Systematic Review
Provisionally accepted
- 1Rocky Vista University, Parker, United States
- 2Henry Ford Health System, Detroit, United States
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Prostate cancer, the second leading cause of cancer-related mortality among men in the U.S., is projected to cause over 36,000 deaths in 2025. This systematic literature review investigates the association between body mass index (BMI) and prostate cancer incidence, evaluating evidence from 2004 to October 2025. A comprehensive search of PubMed using the keywords "BMI" and "prostate cancer" and "screening" identified 60 articles, from which 24 relevant studies were selected for direct analysis. While some studies show a positive correlation between higher BMI and increased risk of prostate cancer, others report no significant association or an inverse relationship. Thus, the overall evidence supports a neutral relationship between BMI and prostate cancer risk. The review explores potential biological mechanisms linking BMI to prostate cancer, including metabolic dysregulation, hormonal changes, and genetic factors. Additionally, it examines how factors such as age, race/ethnicity, and socioeconomic status may modify this relationship. The review highlights that although a higher BMI is generally associated with increased prostate cancer risk and poorer outcomes, the evidence is inconsistent. Key limitations include high variability in study designs and outcome measures, short follow-up periods as well as studies predominantly from Western populations. These inconsistencies underscore the need for further research to clarify the relationship and improve targeted interventions to mitigate prostate cancer's impact.
Keywords: BMI, cancer screening, metabolic dysregulation, Obesity, prostate cancer
Received: 12 Dec 2025; Accepted: 05 Feb 2026.
Copyright: © 2026 Myers, Chissum Lagos, Zapata and Hwang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Isain Zapata
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.